Block Listing Six Monthly Return
27 January 2023, 09:00 UTC By inhc
27 January 2023, 09:00 UTC By inhc
Induction Healthcare Group PLC
(“Induction”, the “Company”, or the “Group”)
Block Listing Six Monthly Return
Induction Healthcare (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide, makes the following six-monthly update on its block listing pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies:
Name of applicant: |
Induction Healthcare Group PLC LEI: 213800RY96GCZQW5TP19 |
|||
Name of scheme: |
The Induction Healthcare NTA Share Option Plan |
|||
Period of return: |
From: 27/07/2022 To:26/01/2023 |
|||
Number and class of securities originally admitted and the date of admission |
3,500,000 ordinary shares on 26 July 2021 |
|||
Balance of unallotted securities under scheme(s) from initial application: |
3,103,433 |
|||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
Nil |
|||
Less: Number of securities issued/allotted under scheme(s) during the period: |
Nil |
|||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
3,103,433 |
|||
Contact: |
Louise Torr, Company Secretary louise.t@inductionhealthcare.com |
ENQUIRIES Induction Christopher Samler, Executive Chair Paul Tambeau, Chief Operating Officer |
Via Walbrook PR Ltd: induction@walbrookpr.com |
Singer Capital Markets (Nominated Adviser and Broker) |
+44 (0)20 7496 3000 |
Philip Davies |
|
Walbrook PR Ltd |
induction@walbrookpr.com |
Paul McManus / Alice Woodings |
Mob: +44(0)7980 541 893 / +44 (0)7407 804 654 |
About Induction – www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face – giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.